Point of Care Diagnostics Market Growth and Recent Trends by Forecast to 2028

According to our new research study on "Point of Care Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Prescription Mode, and End User," the market is expected to reach US$ 82,958.3 million by 2028 from US$ 36,000.4 million in 2021; it is estimated to grow at a CAGR of 12.7% from 2021 to 2028. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The market growth is primarily attributed to increase in prevalence of infectious diseases, product developments and launches, and rise in number of CLIA-waived POC tests. However, product recalls are expected to hamper the market growth.

Download PDF Sample Copy at:
https://www.theinsightpartners.com/sample/TIPRE00006394/?utm_source=OpenPR&utm_medium=10376

Based on prescription mode, the point of care diagnostics market is bifurcated into prescription-based testing and OTC testing. In 2020, the prescription-based testing segment held a larger share of the market and is expected to register a higher CAGR during the forecast period. The growth of this segment is mainly attributed to the increasing incidence and prevalence of lifestyle diseases and the lack of awareness on OTC POCT devices in developing nations.

The structure of the Point of Care Diagnostics Market report can be categorized into following sections:

• Section 1: Scope of the Report & Research Methodology
• Section 2: Key Takeaways
• Section 3: Market variables & their impact on growth and analytical tools providing High Level Insights into the Market Dynamics and Growth Pattern
• Section 4: Market Estimates and Forecasts (with the base year as 2022, historic information of 2019 & 2021 and forecast from 2022 to 2028). Regional and Country Level Estimates and Forecasts for each category which are summed up to form the Global Market.
• Section 5: Competitive Landscape. Attributes such as Strategy Framework, Competitor Categorization are included to provide elaborate details on the Market Structure & Strategic Undertakings as well as their impact.

Have a Call with Analyst:
https://www.theinsightpartners.com/speak-to-analyst/TIPRE00006394/?utm_source=OpenPR&utm_medium=10376

The point of care diagnostics market is witnessing substantial growth amid the COVID-19 pandemic. Certain factors such as sudden rise in coronavirus infections and exponential growth in COVID-19 diagnostic kits played a prominent role in the growth of the point of care diagnostics market during the pandemic. In addition, the growing demand for rapid test kits for faster diagnosis at public places is also estimated to have a positive impact on the market growth.

F. HOFFMANN-LA ROCHE LTD.; Danaher; BIO-RAD LABORATORIES INC.; Abbott; Johnson and Johnson Services, Inc.; Siemens AG; BD; BioMerieux SA; Polymer Technology Systems, Inc. (PTS); and Nova Biomedical are among the leading companies operating in the point of care diagnostics market.

Buy Report at:
https://www.theinsightpartners.com/buy/TIPRE00006394/?utm_source=OpenPR&utm_medium=10376

Contact us:

If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-987

About The Insight Partners:

The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Manufacturing and Construction, Technology, Chemicals and Materials.
We offer our clients multiple ways to customize research as per their specific needs and budget.

This release was published on openPR.